NeuroMetrix Completes 510(k) Clearance Process for SENSUS™ Pain Management System WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 29, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes,
NeuroMetrix to Present at Canaccord Genuity Medical Technology & Diagnostics Forum WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 27, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes,
NeuroMetrix Announces Distribution Agreement with OneSource Medical Group for SENSUS Pain Management Device WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 1, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of
NeuroMetrix, Inc. Announces Date for 2012 Third Quarter Financial Results Conference Call WALTHAM, Mass. --(BUSINESS WIRE)--Oct. 15, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2012 third quarter financial results before the opening of the market on October 25, 2012 .
NeuroMetrix Receives Six Month Extension of Grace Period to Regain Compliance With NASDAQ Listing Requirements WALTHAM, Mass. --(BUSINESS WIRE)--Sep. 20, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has received a letter from The NASDAQ Stock Market LLC (“NASDAQ”) stating that it
NeuroMetrix to Present at Rodman & Renshaw Annual Global Investment Conference WALTHAM, Mass. --(BUSINESS WIRE)--Sep. 5, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes,
NeuroMetrix Receives 510(k) Clearance for SENSUS™ Pain Management Device WALTHAM, Mass. --(BUSINESS WIRE)--Aug. 6, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced